| ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer (NCT00662597) | Novartis Pharmaceuticals | 2008-04-01 |
| Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension. (NCT00698646) | Novartis Pharmaceuticals | 2008-04-01 |
| Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease (NCT00690430) | Novartis Pharmaceuticals | 2008-04-01 |
| Evaluation of Octreotide LAR in Prevention of Chemotherapy-induced Diarrhea (NCT00582426) | Novartis Pharmaceuticals | 2008-04-01 |
| An Open-label, Phase I Trial of Intravenous ASA404 Administered in Combination With Paclitaxel and Carboplatin in Japanese Patients With Non-Small Cell Lung Cancer (NSCLC) (NCT00674102) | Novartis Pharmaceuticals | 2008-04-01 |
| Cardiac Safety of Indacaterol (NCT01263808) | Novartis Pharmaceuticals | 2008-04-01 |
| A Trial of Panobinostat and Trastuzumab for Adult Female Patients With HER2 Positive Metastatic Breast Cancer (MBC) Whose Disease Has Progressed on or After Trastuzumab (NCT00567879) | Novartis Pharmaceuticals | 2008-04-01 |
| Treatment of Patients With RAD001 With Progressive Sarcoma (NCT00767819) | Novartis Pharmaceuticals | 2008-03-31 |
| Efficacy and Safety Study of Panobinostat in Participants With Metastatic Hormone Refractory Prostate Cancer (NCT00667862) | Novartis Pharmaceuticals | 2008-03-18 |
| A Study Designed to Compare the Tolerability of an Increased Dose of Enteric-coated Mycophenolate Acid (MPA) in Renal Transplant Patients Whose Dose of Mycophenolate Mofetil (MMF) Was Reduced Due to Gastrointestinal Symptoms (NCT00658333) | Novartis Pharmaceuticals | 2008-03-01 |
| Prospective Exploratory Study to Describe Hepatitis B Virus (HBV) Kinetics During Treatment With Telbivudine (NCT00640588) | Novartis Pharmaceuticals | 2008-03-01 |
| Rheumatological Evaluation of Anastrozole and Letrozole as Adjuvant Treatment in Post-menopausal Women With Breast Cancer (NCT00688909) | Novartis Pharmaceuticals | 2008-03-01 |
| Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies (NCT00670592) | Novartis Pharmaceuticals | 2008-03-01 |
| A Phase I Dose Escalation Study of RAD001 Administered in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT00622258) | Novartis Pharmaceuticals | 2008-03-01 |
| Evaluation of Early Conversion to Everolimus From Cyclosporine in de Novo Renal Transplant Recipients (NCT00634920) | Novartis Pharmaceuticals | 2008-03-01 |
| Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly (NCT00600886) | Novartis Pharmaceuticals | 2008-02-11 |
| Efficacy and Safety of Oral Deferasirox (20 mg/kg/d) in Pts 3 to 6 Months After Allogeneic Hematopoietic Cell Transplantation Who Present With Iron Overload (NCT00654589) | Novartis Pharmaceuticals | 2008-02-01 |
| Observational and Epidemiologic Study of the Disease Course and Unmet Needs in Children With Symptomatic Moderate to Severe Allergic Asthma (NCT01362621) | Novartis Pharmaceuticals | 2008-02-01 |
| A Single-arm Study Evaluating the Efficacy and Safety of Telbivudine With or Without add-on Tenofovir in Adults With HBeAg-positive Chronic Hepatitis B (CHB) (NCT00651209) | Novartis Pharmaceuticals | 2008-02-01 |
| A Dose Finding Study With I.V. Panobinostat (LBH589), Docetaxel, and Prednisone in Patients With Hormone Refractory Prostate Cancer (NCT00663832) | Novartis Pharmaceuticals | 2008-02-01 |
| Drug Use Investigation for ARRANON G (Nelarabine) Injection 250mg (NCT01376115) | Novartis Pharmaceuticals | 2008-01-18 |
| Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) Study (NCT00553358) | Novartis Pharmaceuticals | 2008-01-05 |
| Efficacy and Tolerability of STI571 (Imatinib Mesylate) for the Treatment of Fibrosis in Participants With Systemic Sclerosis (NCT00613171) | Novartis Pharmaceuticals | 2008-01-02 |
| Effect of the Fixed Dose Combination Amlodipine/Valsartan on Central Aortic Blood Pressure in Uncontrolled Essential Hypertension With Amlodipine 5 mg (NCT00687973) | Novartis Pharmaceuticals | 2008-01-01 |
| A Crossover Study to Determine the 24 Hour Lung Function Profile of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) (NCT00622635) | Novartis Pharmaceuticals | 2008-01-01 |
| Efficacy and Safety of Concentration-controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de Novo Liver Transplant Recipients (NCT00622869) | Novartis Pharmaceuticals | 2008-01-01 |
| QAX576 in Patients With Pulmonary Fibrosis Secondary to Systemic Sclerosis (NCT00581997) | Novartis Pharmaceuticals | 2007-12-01 |
| Efficacy and Safety of QVA149 in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT00570778) | Novartis Pharmaceuticals | 2007-12-01 |
| A Phase I/II Study of BGT226 in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer (NCT00600275) | Novartis Pharmaceuticals | 2007-12-01 |
| Efficacy of Everolimus as Inhibitor of Fibrosis Progression in Liver Transplant Patients With Recurrence of Hepatitis C Viral Infection (NCT00582738) | Novartis Pharmaceuticals | 2007-12-01 |
| Effect of AQW051 in Patients With Memory Impairment (NCT00582855) | Novartis Pharmaceuticals | 2007-12-01 |
| Evaluating the Efficacy of Deferasirox in Transfusion Dependent Chronic Anaemias (Myelodysplastic Syndrome, Beta-thalassaemia Patients) With Chronic Iron Overload (NCT00564941) | Novartis Pharmaceuticals | 2007-12-01 |
| Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Participants (NCT00622505) | Novartis Pharmaceuticals | 2007-11-07 |
| Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma (NCT00535951) | Novartis Pharmaceuticals | 2007-11-01 |
| Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload (NCT00600938) | Novartis Pharmaceuticals | 2007-11-01 |
| A Study to Investigate the Effect of Food on Oral LBH589 Absorption in Patients With Advanced Solid Tumors (NCT00570284) | Novartis Pharmaceuticals | 2007-11-01 |
| Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis (NCT00631163) | Novartis Pharmaceuticals | 2007-10-01 |
| Comparison of Aliskiren and Amlodipine on Insulin Resistance and Endothelial Dysfunction in Patients With Hypertension and Metabolic Syndrome (NCT00417170) | Novartis Pharmaceuticals | 2007-10-01 |
| Glivec® Plus m-FOLFOX Avastin® in Advanced Colorectal Cancer (NCT01271166) | Novartis Pharmaceuticals | 2007-10-01 |
| Efficacy of a Combination of Amlodipine/Valsartan on 24H Blood Pressure Control With One Nocturnal or Diurnal Intake a Day (NCT00700271) | Novartis Pharmaceuticals | 2007-10-01 |
| Nilotinib vs Imatinib in Adult Patients With Philadelphia (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) (NCT00519090) | Novartis Pharmaceuticals | 2007-10-01 |
| Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) (NCT00549757) | Novartis Pharmaceuticals | 2007-10-01 |
| A Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via TWISTHALER® Device in Adult and Adolescent Patients With Persistent Asthma (NCT00545272) | Novartis Pharmaceuticals | 2007-10-01 |
| A Study of Dex-methylphenidate Extended Release in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD) (NCT00564954) | Novartis Pharmaceuticals | 2007-10-01 |
| Treatment of Patients Suffering From a Progressive Pancreas Carcinoma With Everolimus (RAD001) and Gemcitabine (NCT00560963) | Novartis Pharmaceuticals | 2007-10-01 |
| Safety Study of LBH589 When Given in Combination With Bortezomib in Adult Patients With Multiple Myeloma (NCT00532389) | Novartis Pharmaceuticals | 2007-10-01 |
| 24 Month Extension to Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients(Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients (NCT00555789) | Novartis Pharmaceuticals | 2007-10-01 |
| A Study to Investigate the Effects of Ketoconazole on LBH589 in Patients With Advanced Solid Tumors (NCT00503451) | Novartis Pharmaceuticals | 2007-09-01 |
| Efficacy and Safety of LCZ696A in Patients With Essential Hypertension (NCT00549770) | Novartis Pharmaceuticals | 2007-09-01 |
| SD, IL-13 Production Rate in IPF (NCT00532233) | Novartis Pharmaceuticals | 2007-09-01 |
| Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma (NCT00529529) | Novartis Pharmaceuticals | 2007-09-01 |
| Phase I Study to Examine the Effect of Deferasirox on Renal Hemodynamics in β-thalassemia Patients With Transfusional Iron Overload (NCT00560820) | Novartis Pharmaceuticals | 2007-09-01 |
| Efficacy and Safety of Everolimus (RAD001) in Patients With Advanced Gastric Cancer (NCT00519324) | Novartis Pharmaceuticals | 2007-08-01 |
| Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM) (NCT00515086) | Novartis Pharmaceuticals | 2007-08-01 |
| To Evaluate Antiviral Efficacy of Telbivudine in Hepatitis B Antigen Positive (HbeAg-positive) Compensated Chronic Hepatitis B (CHB) (NCT00537537) | Novartis Pharmaceuticals | 2007-08-01 |
| A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) (NCT00471497) | Novartis Pharmaceuticals | 2007-07-31 |
| Lapatinib +Capecitabine Treatment for Advanced Metastatic Breast Cancer in Women From China (NCT00508274) | Novartis Pharmaceuticals | 2007-07-18 |
| Study of Oral LBH589 in Adult Participants With Refractory/Resistant Cutaneous T-Cell Lymphoma (CTCL) (NCT00490776) | Novartis Pharmaceuticals | 2007-07-05 |
| Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer (NCT00426556) | Novartis Pharmaceuticals | 2007-07-01 |
| Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine Tumors (NCT00510068) | Novartis Pharmaceuticals | 2007-07-01 |
| Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients (NCT00526045) | Novartis Pharmaceuticals | 2007-07-01 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QAU145 in Patients With Cystic Fibrosis (NCT00506792) | Novartis Pharmaceuticals | 2007-07-01 |
| Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies (Extension) (NCT00442741) | Novartis Pharmaceuticals | 2007-07-01 |
| Study Investigating a Standard Regimen in de Novo Kidney Transplant Patients Versus a Calcineurin Inhibitor (CNI)-Free Regimen and a CNI-low Dose Regimen (NCT00514514) | Novartis Pharmaceuticals | 2007-07-01 |
| Efficacy, Safety and Tolerability of AEB071 Versus Cyclosporine in the Novo Renal Transplant Recipients (NCT00504543) | Novartis Pharmaceuticals | 2007-07-01 |
| Efficacy and Safety of Four Doses of Glycopyrronium Bromide (NVA237) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD), in Comparison to an Active Comparator Tiotropium (NCT00501852) | Novartis Pharmaceuticals | 2007-07-01 |
| Observational Registry Study of Renal Transplant Patients (NCT01284257) | Novartis Pharmaceuticals | 2007-06-01 |
| Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline (NCT00506415) | Novartis Pharmaceuticals | 2007-06-01 |
| Extension Study to Assess Long Term Safety, Tolerability, and Efficacy of Valsartan and Enalapril Combined and Alone in Children With Hypertension (NCT00446511) | Novartis Pharmaceuticals | 2007-06-01 |
| Acetaminophen or Fluvastatin Compared to Placebo on the Transient Post-Dose Symptoms (PDS) Following an Intravenous (i.v.) Infusion of a Single Dose of Zoledronic Acid 5mg, in Post-menopausal Women With Low Bone Mass (NCT00489424) | Novartis Pharmaceuticals | 2007-06-01 |
| ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D (NCT00490139) | Novartis Pharmaceuticals | 2007-05-16 |
| Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndrome and Transfusion-dependent Iron Overload (NCT00481143) | Novartis Pharmaceuticals | 2007-05-01 |
| The Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies (NCT00468260) | Novartis Pharmaceuticals | 2007-05-01 |
| ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox (NCT00466063) | Novartis Pharmaceuticals | 2007-05-01 |
| A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer (NCT00478634) | Novartis Pharmaceuticals | 2007-05-01 |
| A Study to Determine the Absorption, Distribution, Metabolism, and Excretion of LBH589 (NCT00472368) | Novartis Pharmaceuticals | 2007-05-01 |
| Efficacy and Safety of LBH589B in Adult Patients With Multiple Myeloma (NCT00445068) | Novartis Pharmaceuticals | 2007-04-16 |
| A Study to Evaluate the Long-term Use of Valsartan in Children 6 Months to 5 Years Old With Hypertension (NCT00457626) | Novartis Pharmaceuticals | 2007-04-09 |
| An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B (NCT00467545) | Novartis Pharmaceuticals | 2007-04-01 |
| Pharmacokinetics and Pharmacodynamics of BCT194 in Psoriatic Patients (NCT01539915) | Novartis Pharmaceuticals | 2007-04-01 |
| Safety of RAD001 in Combination With Cisplatin and Etoposide in Lung Cancer Patients (NCT00466466) | Novartis Pharmaceuticals | 2007-04-01 |
| Efficacy and Tolerability of Full Dose Enteric-coated Mycophenolate Sodium, in Addition to Cyclosporine for Microemulsion Reduced Dose, in Maintenance Renal Transplant Recipients (NCT00434590) | Novartis Pharmaceuticals | 2007-03-01 |
| Evaluate the Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies (NCT00448396) | Novartis Pharmaceuticals | 2007-03-01 |
| Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS (NCT00324025) | Novartis Pharmaceuticals | 2007-03-01 |
| Efficacy and Safety of Nilotinib (AMN107) Compared With Current Treatment Options in Patients With GIST Who Have Failed Both Imatinib and Sunitinib (NCT00471328) | Novartis Pharmaceuticals | 2007-03-01 |
| Dose Response of Valsartan on Sitting Systolic Blood Pressure in Children 6 Months - 5 Years of Age With High Blood Pressure (NCT00435162) | Novartis Pharmaceuticals | 2007-03-01 |
| Lapatinib and Bevacizumab for Metastatic Breast Cancer (NCT00444535) | Novartis Pharmaceuticals | 2007-02-27 |
| Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia in Accelerated or Blast Phase (NCT00449761) | Novartis Pharmaceuticals | 2007-02-23 |
| Efficacy and Safety of LBH589 in Adult Patients With Refractory Chronic Myeloid Leukemia (CML) in Chronic Phase (NCT00451035) | Novartis Pharmaceuticals | 2007-02-19 |
| A Clinical Study to Evaluate the Safety, Tolerability and Activity of a New Phosphate Binder (SBR759) in Patients With Chronic Kidney Disease on Hemodialysis (NCT00750295) | Novartis Pharmaceuticals | 2007-02-01 |
| Combined Antiinflammatory and Angiostatic Therapy in Patients With Hormone-refractory Prostate Cancer (NCT00427999) | Novartis Pharmaceuticals | 2007-02-01 |
| Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Combination With Two Corticosteroid Regimens for the Treatment of Lupus Nephritis Flare (NCT00423098) | Novartis Pharmaceuticals | 2007-02-01 |
| Combination of RAD001 With Carboplatin, Paclitaxel and Bevacizumab in Non-small-cell Lung Cancer (NSCLC) Patients (NCT00457119) | Novartis Pharmaceuticals | 2007-02-01 |
| Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer (NCT00426530) | Novartis Pharmaceuticals | 2007-02-01 |
| A Study Comparing AIN457 to Placebo in Subjects With a Diagnosis of Moderate to Severe Stable Plaque Psoriasis (NCT00669916) | Novartis Pharmaceuticals | 2007-02-01 |
| Efficacy/Safety of Valsartan Plus Amlodipine and Valsartan Alone in Patients With Hypertension (NCT00413413) | Novartis Pharmaceuticals | 2007-01-01 |
| Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease (NCT00423085) | Novartis Pharmaceuticals | 2007-01-01 |
| Effect of Valsartan Compared to Enalapril on Sitting Systolic Blood Pressure in Children With High Blood Pressure (NCT00433836) | Novartis Pharmaceuticals | 2007-01-01 |
| An Extension Trial to a Phase I Dose Escalation Study of Gimatecan Administered Orally 5 Consecutive Days to Japanese Patients With Advanced Solid Tumor (NCT00441610) | Novartis Pharmaceuticals | 2007-01-01 |
| Measurement of Gastrointestinal (GI) and Health-related Quality of Life (HRQL) Outcomes in Liver Transplant Recipients (NCT00405652) | Novartis Pharmaceuticals | 2007-01-01 |